Multiple Sclerosis Journal · 2019 · 35 citations · 23 references
Life SciencesImmunologyNeurologyAutoimmunityNeuroimmunologyStem Cell TransplantationAutoimmune Neurological DisordersCerebrospinal Fluid ImmunologyDemyelinating DiseasesDemyelinating DisordersImmunoglobulin FunctionMultiple SclerosisAutologous Stem Cell TherapyCerebrospinal Fluid DiagnosisCerebrospinal Fluid Immunoglobulin ClassesImmunoglobulin ProductionIntrathecal Immunoglobulin SynthesisNeurofilament AbnormalitiesNeurofilament PathologyRetrospective Case Study
BACKGROUND: Oligoclonal bands (OCB) are widely believed to be stable over time and rarely affected by disease-modifying treatment in MS. It is presently unknown how intrathecal immunoglobulin production and other cerebrospinal fluid (CSF) biomarkers are impacted by a highly efficacious procedure such as autologous haematopoietic stem cell transplantation (aHSCT). OBJECTIVE: To describe the evolution of intrathecal immunoglobulin and neurofilament light (NFL) over time in MS patients treated with aHSCT. METHODS: In this retrospective study, available data from previously made CSF investigations in 46 patients treated with aHSCT were analysed. RESULTS: After a median follow-up time of 745 days, immunoglobulin G (IgG) OCB remained detectable in 74% of patients, the proportion of patients with a pathological IgG index went down from 70% to 46%, and the proportion of patients with a pathological NFL went down from 72% to 24%. In patients with follow-up time >1500 days, IgG OCB were detectable in 50% of patients, 14% had a pathological IgG index and none a pathological NFL. CONCLUSIONS: Intrathecal immunoglobulin production and NFL were lower after treatment with aHSCT, decreased over time and were normalised in a significant portion of patients. This challenges the notion that OCB are unaffected by therapeutic intervention in MS.
23
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
Giulio Disanto, Christian Barro, Pascal Benkert et al. · Annals of Neurology · 2017 · 1.2K citations · Full text
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
Claire Bridel, Wessel N. van Wieringen, Henrik Zetterberg et al. · JAMA Neurology · 2019 · 760 citations · Full text
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
Lenka Novakova, Henrik Zetterberg, Peter Sundström et al. · Neurology · 2017 · 428 citations · Full text